Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes mellitus: Is the Chance of Complete Remission Dependent on Therapy and Duration of Insulin Treatment?

被引:9
|
作者
Cho, Eun-Young [1 ]
Kemmet, Olga [1 ]
Frenken, Michael [1 ]
机构
[1] St Josef Krankenhaus Monheim, Dept Surg, D-40789 Monheim, Germany
关键词
Biliopancreatic diversion with duodenal switch; BPD-DS; Type 2 diabetes mellitus; Complete remission; Insulin; OBESE-PATIENTS; SENSITIVITY; GLUCOSE; RESISTANCE; SURGERY; TERM;
D O I
10.1159/000327037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Rapid resolution of type 2 diabetes mellitus (T2DM) is a common feature after intestinal bypass surgery bypassing the duodenum and parts of the jejunum. However, the parameters determining the individual chance of remission are imprecisely defined. Methods: Biliopancreatic diversion with duodenal switch and sleeve gastrectomy (BPD-DS) was performed in n = 86 patients with T2DM (mean age 50 years, range 26-68, 51 females; BMI 47 kg/m(2), range 26-71). The patients were retrospectively divided into 4 groups according to the treatment modality and the duration of insulin treatment preoperatively: n = 18 patients were treated with oral antidiabetic drugs only (group 1); n = 32, n = 24, and n = 12 patients were treated with insulin for less than 5 years, for 5-10 years, and for more than 10 years (groups 2, 3, and 4), respectively. Results: At discharge from hospital, all patients of groups 1 and 2 were free of insulin usage, 30% and 75% of the patients of groups 3 and 4 used up to 48 units of insulin per day (mean 24, n = 16). After 1 year, only 4 patients of group 4 permanently required small amounts of insulin (mean 17 units per day) to keep blood glucose below 200 mg/dl. These 4 patients had been using insulin preoperatively for 13, 15, 22, and 25 years. In 3 of these 4 patients, fasting C-peptide was measured and found to be low (<1.2 ng/ml). The rate of complete remission of diabetes for the whole study population was 91%. Conclusion: BPD-DS reliably causes rapid and complete remission of T2DM in all patients on oral antidiabetic drugs and in patients with insulin treatment for less than 5 years. In patients with insulin treatment longer than 5 or 10 years, complete remission rates decline to 88 and 66%, respectively. A low C-peptide preoperatively might be a specific adverse prognostic parameter for the chance of diabetes remission.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [31] Prediction of Type 2 Diabetes Remission at Long-term Following Biliopancreatic Diversion: the Relative Role of Different Metabolic Attitudes
    Adami, Gian Franco
    Cordera, Renzo
    OBESITY SURGERY, 2021, 31 (09) : 4159 - 4160
  • [32] Risk perceptions of patients with type 2 diabetes mellitus regarding insulin therapy and diabetes complications: A cross-sectional study
    Saglam, Fatma Sinem
    Bektas, Hicran
    JOURNAL OF CLINICAL NURSING, 2023, 32 (15-16) : 5010 - 5027
  • [33] Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus
    Rochester, Charmaine D.
    Leon, Nicholas
    Dombrowski, Robert
    Haines, Stuart T.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (01) : 42 - 48
  • [34] Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
    Kubo, Sayaka
    Watada, Hirotaka
    Kawamori, Ryuzo
    JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (1-2) : 60 - 65
  • [35] Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study
    Hohberg, C.
    Pfuetzner, A.
    Forst, T.
    Luebben, G.
    Karagiannis, E.
    Borchert, M.
    Schoendorf, T.
    DIABETES OBESITY & METABOLISM, 2009, 11 (05) : 464 - 471
  • [36] Should biliopancreatic diversion with duodenal switch be done as single-stage procedure in patients with BMI ≥50 kg/m2?
    Topart, Philippe
    Becouarn, Guillaume
    Ritz, Patrick
    SURGERY FOR OBESITY AND RELATED DISEASES, 2010, 6 (01) : 59 - 63
  • [37] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [38] Insulin sensitivity and mortality risk estimation in patients with type 2 diabetes mellitus
    Akinlade, K. S.
    Habila, K. G.
    Rahamon, S. K.
    Ogundeji, O. A.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2017, 20 (06) : 767 - 773
  • [39] Rejection of insulin therapy among patients with type 2 diabetes in China: reasons and recommendations
    Xiong Zhenzhen
    Yuan Li
    Guo Xiaohui
    Lou Qingqing
    Zhao Fang
    Shen Li
    Zhang Mingxia
    Sun Zilin
    CHINESE MEDICAL JOURNAL, 2014, 127 (20) : 3530 - 3536
  • [40] The use of insulin in elderly patients with type 2 diabetes mellitus
    Mannucci, Edoardo
    Cremasco, Francesco
    Romoli, Ester
    Rossi, Andrea
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2865 - 2881